Financial Planning and Analysis Associate Director

Financial Planning & Analysis Associate Director

Location: 50 Northern Ave., Boston, Massachusetts, 02210

Openings: 1

• Provide financial direction and strategic insight to functional leaders, defining and delivering short‑term and long‑term goals, including identification of key value drivers and Business KPIs.
• Provide strategic decision support, influencing decisions and identifying opportunities to invest, save costs, and mitigate risks on a global basis.
• Lead the financial planning process for areas of responsibility including budget, forecast, and long‑range plan, developing key scenarios and identifying key risks and uncertainties for potential mitigation.
• Lead financial performance management for areas of responsibility, including monthly accruals, forecast, and operating review, with a focus on understanding key drivers of short‑term performance and communicating a range of possible outcomes.
• Design, enhance, and maintain business valuation and cost of goods sold (COGS) financial models, providing COGS and gross margin analysis and identifying cost improvement opportunities at launch and over the long term.
• Partner within FP&A and with accounting, DTE, and HR to ensure clear ownership and management of deliverables from those teams and that finance services are delivered seamlessly to the business.
• Ensure financial integrity and robust corporate governance and compliance of financial aspects for areas of responsibility.
• Telecommuting permitted up to 40% of the workweek.

• Bachelor’s degree in Business Administration, Finance, Accounting or a related field and 8 years of experience in FP&A or a related occupation.
• Experience calculating COGS and manufacturing costing for biologics products in the pharmaceutical industry.
• Understanding of overall pharmaceutical manufacturing and supply chain expenses.
• Experience building financial models to assess manufacturing network strategy, including supplier location decisions, risk assessment, geopolitical impacts, and gross margin effects.
• Experience with capital expense (Cap Ex) investments significant to the pharmaceutical industry and business partnering with executive leadership.
• Strong skills utilizing MS Office and financial software applications, including Oracle Hyperion for reporting and consolidation.
• Experience building automation in financial software, including Power BI dashboards.
• Experience using inventory management systems such as Oracle Inventory Management to measure inventory levels.
• Ability to coordinate budget and forecast financial cycles, assess future manufacturing and supply chain expenses, consolidate data, and challenge stakeholder assumptions.
• Experience assessing future expenses and investments required over the next fiscal year or next 10 years (long‑range planning).
• Ability to coordinate COGS across the biologics portfolio, leveraging it to assess product profitability and strategic financial calculations.
• Experience conducting portfolio analysis, valuation, and ROI/ROIC assessments.
• Strong analytical skills for forecast cycle variance analysis, identifying whether expenses are higher or lower than expectations and anticipating company risk or opportunity.
• Experience analyzing manufacturing cost to determine future biologics portfolio COGS and understand drug substance performance and overhead costing.
• Experience articulating volume production relying on pharmaceutical manufacturing chain knowledge.
• Experience conducting net present value (NPV) financial analysis to evaluate manufacturing network strategy investments, building and P&L models, and comparing scenarios to assess financial profitability.
• Serve as a key financial leader to the executive team, providing financial direction through expense assessment, contributing monthly strategic insight, and explaining variances versus forecast cycles.
• Develop remediation plans to avoid risks and overspending and identify opportunities to compensate risk.
• Experience assessing manufacturing chain investment scenarios, including supplier investments exceeding $50 million USD, and providing guidance on investment financial implications.
• Experience calculating…